Effects of Immunoproteasome Inhibition on Adenovirus Pathogenesis
Danielle Malitz
openalex +1 more source
Immunoproteasome components LMP2, PSME1, and PSME2 as novel tissue biomarkers predicting response and survival in neoadjuvant chemoimmunotherapy for resectable NSCLC. [PDF]
Xie R, Zhai K, Yu J, Zhao M.
europepmc +1 more source
Plasticity in the structure and assembly of proteasomes. [PDF]
Chang AH, Sengupta S, Tomko RJ.
europepmc +1 more source
Developmental Phase-Specific Molecular Signatures and Signaling Pathways in Cryptorchidism-Induced Testicular Damage. [PDF]
Wang X +11 more
europepmc +1 more source
Proteomic profiling of bronchoalveolar lavage following human segmental endotoxin challenge-a potential exacerbation model. [PDF]
Gress C, Müller M, Hohlfeld JM.
europepmc +1 more source
PI31 is a positive regulator of 20S immunoproteasome assembly.
Wang J, Kjellgren A, DeMartino GN.
europepmc +1 more source
Related searches:
Immunoproteasomes and immunosenescence
Ageing Research Reviews, 2003Aging is a complex process which is accompanied with the decline and the reshaping of different functions of the body. In particular the immune system is characterized, during ageing (immunosenescence) by a remodeling of innate immunity (well preserved, up-regulated) and clonotypical immunity (severely altered) and by the occurrence of a chronic ...
Mishto M. +5 more
openaire +3 more sources
Proteasomes and immunoproteasomes.
Rivista di biologia, 2011In eukaryotic cells, the protein degradation is a highly regulated and selective process. Membrane-associated or extracellular proteins are degraded in lysosomes, whereas intracellular protein dismantling is primarily non-lysosomal, being realized by complex, not-membrane enclosed and energy-dependent effectors, the proteasomes, localized in both ...
Fietta, Pieranna, Delsante, Giovanni
openaire +2 more sources
On the role of the immunoproteasome in transplant rejection [PDF]
The immunoproteasome is expressed in cells of hematopoietic origin and is induced during inflammation by IFN-γ. Targeting the immunoproteasome with selective inhibitors has been shown to be therapeutically effective in pre-clinical models for autoimmune diseases, colitis-associated cancer formation, and transplantation.
Michael Basler, Jun Li, Marcus Groettrup
exaly +4 more sources

